We only have this paper's title and publication details.
Read it at the sourceCaptured external expert commentary on this paper, strongest first. Original sources are linked where available.
“The idea that we just implant the valve and as long as there is no [paravalvular leak] and no big gradient, it's fine, I think is probably not correct. I think that's an important message.”
“This decision is considered a consequential response to disappointing results in the randomized IDE trial with Acurate neo2, which was preceded several years ago by negative outcomes in the SCOPE I and SCOPE II trials with the first-generation Acurate neo valve. Hence, critical voices may perceive this withdrawal as scientific reckoning, but this warrants a nuanced interpretation.”
“I think it's fair to say that valve design modification to increase radial strength and careful consideration of pre- and postdilatation may improve valve expansion. Whether improvement and optimisation of Acurate neo2 valve expansion translates into better clinical outcomes is something that needs to be further investigated.”
No takes yet. Share an insight, caveat, or question.
Penteris et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: